Skip to content

Clinical trials

Multiple Sclerosis, Chronic Progressive trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Chronic Progressive Phase: Not applicable Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20122
20131
20144
20152
20161
20175
20184
20194
20202
20211
20225
20236
20243
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Unknown status10
Recruiting6
Terminated4
Active, not recruiting2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shirley Ryan AbilityLab4
Hicks, Audrey, Ph.D.2
Klinik Valens2
Somogy Megyei Kaposi Mór Teaching Hospital2
University Hospital, Montpellier2
Universitätsklinikum Hamburg-Eppendorf2
Amsterdam UMC, location VUmc1
Aristotle University Of Thessaloniki1
Assistance Publique - Hôpitaux de Paris1
Association de Recherche Bibliographique pour les Neurosciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Chronic Progressive49
Multiple Sclerosis27
Multiple Sclerosis, Relapsing-Remitting18
Fatigue7
Hypoxia4
Cognitive Dysfunction3
Mobility Limitation2
Nervous System Diseases2
Brain Diseases1
Central Nervous System Diseases1

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.